Filter
69
Featured
Recommendations
3
Language
Document type
No document type
57
Training Material
4
Manuals
2
Studies & Reports
2
Fact sheets
2
Resource Platforms
1
Guidelines
1
Countries / Regions
Ukraine
5
Eastern Europe
5
Russia
5
Global
5
Western and Central Europe
3
Germany
1
Latin America and the Carribbean
1
Asia
1
Estonia
1
Iran
1
Australia
1
Authors & Publishers
Publication Years
Category
Public Health
14
Capacity Building
2
Countries
1
Best practice guidelines are systematically developed statements designed to assist nurses working in partnership with persons and their families to make decisions about health care and services (Field & Lohr, 1990). This nursing Best Practice Guideline (BPG) is intended to replace the RNAO BPGs Scr
...
16-17 march 2015, Geneva, Switzerland
Meeting report
Session outline
•Introduction to dementia
•Assessment of dementia
•Management of dementia
•Follow-up
•Review
Материалы научно-практической конференции с международным участием «Достижения в нейробиологии и терапии болезни Альцгеймера», посвященной памяти профессора Э.
...
Цель настоящего доклада — повысить осведомленность о деменции как
одной из приоритетных проблем общественного здравоохранения, сформу-
лировать подход к этой п
...
Ein kompakter Ratgeber
23. aktualisierte Auflage
Bei der Bewältigung der Alzheimer-Krankheit und anderer Formen der Demenz müssen viele Personen zusammenwirken: der Patient selbst, seine Angehörigen, Freunde und Bekannte, der Hausarzt und spezialisierte Ärzte, oft auch die Mitarbeiter von Be
...
Bull World Health Organ 2013;91:773–783 | doi: http://dx.doi.org/10.2471/BLT.13.118422
(Submitted: 15 February 2013 – Revised version received: 21 June 2013 – Accepted: 22 June 2013 – Published online: 20 August 2013)
Brochure à l’intention des professionnels des structures de
soins ambulatoires ou institutionnels et du travail social auprès des malades et de leurs proches.
Доказательной базой для рекомендаций являются публикации, вошедшие в базы данных PubMed/MEDLINE, данные международных согласительных документов по болезни Альцгеймера:
...
Q5: For people with dementia, which cognitive/psychosocial interventions (such as cognitive stimulation, cognitive rehabilitation, reality orientation, reminiscence therapy) when compared to placebo/comparator produce benefits/harm in the specified outcomes?
The report “Dementia: a public health priority” has been jointly developed by WHO and Alzheimer's Disease International. The purpose of this report is to raise awareness of dementia as a public health priority, to articulate a public health approach and to advocate for action at international a
...
La demencia es una enfermedad gravemente incapacitante para aquellos que la padecen y suele ser devastadora para sus cuidadores y familiares. Se estima que en la actualidad 35.6 millones de personas viven con demencia a nivel mundial. Este número se habrá casi duplicado para el 2030 y más que tri
...
Q9: For carers of people with dementia, do interventions (psychoeducational, cognitive-behavioural therapy counseling/case management, general support, training of caregivers, multi-component interventions and miscellaneous interventions) when compared to placebo/comparator, produce benefits/harm in
...
В методических рекомендациях представлены современные подходы к терапии поведенческих и психотических расстройств у пациентов с болезнью Альцгеймера. Ведение т
...
Q10: For carers of people with dementia, does respite care when compared to care as usual, produce benefits/harm in the specified outcomes?
Q4: For people with dementia with associated depression, do antidepressants when compared to placebo/comparator produce benefits/harm in the specified outcomes?
Q6: Can dementia be diagnosed at first or second level care by non-specialist health care providers? What should be the assessment process for the diagnosis of dementia?
Q8: For people with dementia, what is the role of a medical review (including comorbid physical and mental conditions and medication use)?
Q2: For people with dementia, does memantine, when compared to placebo/comparator, produce benefits/harm in the specified outcomes in non-specialist health settings?